Chady Stephan is the President and Founder of Analyx Consultancy Inc. based in Toronto, Canada. He leverages over 15 years of leadership bridging the gap between complex scientific innovation and commercial success. A Chartered Chemist and multiple patent holder, he specializes in translating technical breakthroughs—such as his pioneering work in Single Particle/Single Cell-ICP-MS and Gas Direct Injection (GDI) analysis—into commercial products.

 

Previously, Dr. Stephan served as Managing Director of Applied Markets at PerkinElmer, Inc. In this role, he spearheaded the organization's strategic pivot from a product-centric to an end-market-focused model, building and expanding a high-caliber team of end-market managers and application scientists. This multidisciplinary approach significantly accelerated product-market fit and streamlined go-to-market execution. His executive experience spans 60+ countries, driving high-performing teams to exceed market growth in the pharmaceutical, environmental, food and industrial sectors.

 

A thought leader with over 40 publications & 1300 citations.  Dr. Stephan holds a Ph.D. in Analytical Chemistry from the Université de Montréal and an Executive MBA from McGill University. He remains dedicated to transforming "working in theory" into "working in the lab" for the global scientific community.